Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth hormone added to rFSH for PCO patients undergoing IVF
IRCT20091012002576N31Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in infertility and polycystic ovary syndrome (PCOS) comparing Growth hormone plus rFSH with rFSH alone (2 arms). Primary endpoint: Ovarian hyperstimulation syndrome. Started Sep 2023; status: completed.
02
Drugs
somatropinrecombinant human follicle stimulating hormone
03
Conditions
infertilitypolycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20091012002576N31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091012002576N31.